{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:12:03Z","timestamp":1789269123380,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/s41409-017-0024-1","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T12:42:49Z","timestamp":1513341769000},"page":"300-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant"],"prefix":"10.1038","volume":"53","author":[{"given":"Karen","family":"Sweiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mactal-Haaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2397\u2013404. https:\/\/doi.org\/10.1093\/jac\/dkw157","journal-title":"J Antimicrob Chemother."},{"key":"24_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","volume":"117","author":"L Pagano","year":"2002","unstructured":"Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, et al. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years\u2019 experience of infection in GIMEMA centres. Br J Haematol. 2002;117:379\u201386.","journal-title":"Br J Haematol"},{"issue":"RR-10","key":"24_CR3","first-page":"1","volume":"49","author":"Centers for Disease C, Prevention, Infectious Disease Society of A, American Society of B, Marrow T.","year":"2000","unstructured":"Centers for Disease C, Prevention, Infectious Disease Society of A, American Society of B, Marrow T. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49(RR-10):1\u2013125. CE121-127","journal-title":"MMWR Recomm Rep."},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/bmt.2009.254","volume":"44","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant. 2009;44:453\u20135. https:\/\/doi.org\/10.1038\/bmt.2009.254","journal-title":"Bone Marrow Transplant."},{"key":"24_CR5","first-page":"267","volume":"15","author":"KR Imrie","year":"1995","unstructured":"Imrie KR, Prince HM, Couture F, Brandwein JM, Keating A. Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. Bone Marrow Transplant. 1995;15:267\u201370.","journal-title":"Bone Marrow Transplant."},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1200\/JCO.1995.13.1.239","volume":"13","author":"MA Lew","year":"1995","unstructured":"Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Kalish LA, et al. Ciprofloxacin versus trimethoprim\/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol. 1995;13:239\u201350. https:\/\/doi.org\/10.1200\/JCO.1995.13.1.239","journal-title":"J Clin Oncol."},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/bmt.2016.133","volume":"51","author":"DA Curi","year":"2016","unstructured":"Curi DA, Duerst RE, Badke C, Bell J, Chaudhury S, Kletzel M, et al. IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients. Bone Marrow Transplant. 2016;51:1394\u20136. https:\/\/doi.org\/10.1038\/bmt.2016.133","journal-title":"Bone Marrow Transplant."},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1089\/152581601317210999","volume":"10","author":"WH Kruger","year":"2001","unstructured":"Kruger WH, Hornung RJ, Hertenstein B, Kern WV, Kroger N, Ljungman P, et al. Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res. 2001;10:895\u2013903. https:\/\/doi.org\/10.1089\/152581601317210999","journal-title":"J Hematother Stem Cell Res."},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1097\/MPH.0000000000000584","volume":"38","author":"LJ Solodokin","year":"2016","unstructured":"Solodokin LJ, Klejmont LM, Scipione MR, Dubrovskaya Y, Lighter-Fisher J. Papadopoulos J. safety and effectiveness of intravenous pentamidine for prophylaxis of Pneumocystis jirovecii pneumonia in pediatric hematology\/oncology patients. J Pediatr Hematol Oncol. 2016;38:e180\u20135. https:\/\/doi.org\/10.1097\/MPH.0000000000000584","journal-title":"J Pediatr Hematol Oncol."},{"key":"24_CR10","unstructured":"U.S. Department of Health and Human Services PHS, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings. 2017. https:\/\/www.cdc.gov\/niosh\/docs\/2004-165\/pdfs\/2004-165.pdf"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1378\/chest.112.3.646","volume":"112","author":"I Girgis","year":"1997","unstructured":"Girgis I, Gualberti J, Langan L, Malek S, Mustaciuolo V, Costantino T, et al. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients. Chest. 1997;112:646\u201353.","journal-title":"Chest."},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","volume":"8 Suppl 1","author":"MJ Atkinson","year":"2005","unstructured":"Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health. 2005;8 Suppl 1:S9\u201324. https:\/\/doi.org\/10.1111\/j.1524-4733.2005.00066.x","journal-title":"Value Health."},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-2-12","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12 https:\/\/doi.org\/10.1186\/1477-7525-2-12","journal-title":"Health Qual Life Outcomes."},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1477-7525-7-36","volume":"7","author":"M Bharmal","year":"2009","unstructured":"Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes. 2009;7:36 https:\/\/doi.org\/10.1186\/1477-7525-7-36","journal-title":"Health Qual Life Outcomes."},{"key":"24_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-3062.2002.t01-1-00008.x","volume":"4","author":"TK Marras","year":"2002","unstructured":"Marras TK, Sanders K, Lipton JH, Messner HA, Conly J, Chan CK. Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation. Transpl Infect Dis. 2002;4:66\u201374.","journal-title":"Transpl Infect Dis."},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/j.1875-9114.1997.tb03781.x","volume":"17","author":"E Warren","year":"1997","unstructured":"Warren E, George S, You J, Kazanjian P. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia. Pharmacotherapy. 1997;17:900\u201316.","journal-title":"Pharmacotherapy."},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/tid.12486","volume":"18","author":"R Diri","year":"2016","unstructured":"Diri R, Anwer F, Yeager A, Krishnadasan R, McBride A. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2016;18:63\u20139. https:\/\/doi.org\/10.1111\/tid.12486","journal-title":"Transpl Infect Dis."},{"key":"24_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1083-8791(00)70050-4","volume":"6","author":"MJ Vasconcelles","year":"2000","unstructured":"Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant. 2000;6:35\u201343.","journal-title":"Biol Blood Marrow Transplant."},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1086\/313509","volume":"29","author":"JP Souza","year":"1999","unstructured":"Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin Infect Dis. 1999;29:1467\u201371. https:\/\/doi.org\/10.1086\/313509","journal-title":"Clin Infect Dis."},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/bmt.2015.131","volume":"50","author":"MJ Lim","year":"2015","unstructured":"Lim MJ, Stebbings A, Lim SJ, Foor K, Hou JZ, Farah R, et al. IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant. Bone Marrow Transplant. 2015;50:1253\u20135. https:\/\/doi.org\/10.1038\/bmt.2015.131","journal-title":"Bone Marrow Transplant"},{"key":"24_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000040719","volume":"99","author":"CM Machado","year":"1998","unstructured":"Machado CM, Macedo MC, Medeiros RS, Massumoto C, Silva AC, Castelli JB, et al. Primary Pneumocystis carinii prophylaxis with aerosolized pentamidine after bone marrow transplantation. Acta Haematol. 1998;99:54\u20136. 40719","journal-title":"Acta Haematol."},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/petr.12441","volume":"19","author":"A Clark","year":"2015","unstructured":"Clark A, Hemmelgarn T, Danziger-Isakov L, Teusink A. Intravenous pentamidine for Pneumocystis carinii\/jiroveci pneumonia prophylaxis in pediatric transplant patients. Pediatr Transplant. 2015;19:326\u201331. https:\/\/doi.org\/10.1111\/petr.12441","journal-title":"Pediatr Transplant"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/INF.0000000000000946","volume":"35","author":"ER Levy","year":"2016","unstructured":"Levy ER, Musick L, Zinter MS, Lang T, Cowan MJ, Weintrub PS, et al. Safe and effective prophylaxis with bimonthly intravenous pentamidine in the pediatric hematopoietic stem cell transplant population. Pediatr Infect Dis J. 2016;35:135\u201341. https:\/\/doi.org\/10.1097\/INF.0000000000000946","journal-title":"Pediatr Infect Dis J."},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/INF.0000000000000044","volume":"33","author":"E Orgel","year":"2014","unstructured":"Orgel E, Rushing T. Efficacy and tolerability of intravenous pentamidine isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology population. Pediatr Infect Dis J. 2014;33:319\u201321. https:\/\/doi.org\/10.1097\/INF.0000000000000044","journal-title":"Pediatr Infect Dis J."},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/INF.0b013e318292f560","volume":"32","author":"JM DeMasi","year":"2013","unstructured":"DeMasi JM, Cox JA, Leonard D, Koh AY, Aquino VM. Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation. Pediatr Infect Dis J. 2013;32:933\u20136. https:\/\/doi.org\/10.1097\/INF.0b013e318292f560","journal-title":"Pediatr Infect Dis J."},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/pbc.21287","volume":"50","author":"SY Kim","year":"2008","unstructured":"Kim SY, Dabb AA, Glenn DJ, Snyder KM, Chuk MK, Loeb DM. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients. Pediatr Blood Cancer. 2008;50:779\u201383. https:\/\/doi.org\/10.1002\/pbc.21287","journal-title":"Pediatr Blood Cancer."}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-017-0024-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-017-0024-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-017-0024-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T19:22:26Z","timestamp":1719688946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-017-0024-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1038\/s41409-017-0024-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}